2017
DOI: 10.1016/j.radcr.2017.06.017
|View full text |Cite
|
Sign up to set email alerts
|

Myxoid-round cell liposarcoma: MRI appearance after radiation therapy and relationship to response

Abstract: Liposarcomas are classified into 4 different subtypes, with the myxoid-round cell variant demonstrating increased morbidity and metastatic potential dependent on cell composition. Unique to sarcomas, the myxoid-round cell liposarcoma is remarkably sensitive to radiation therapy in the pretreatment setting, owing to the tumor morphology and vascular distribution.Herein we report a case of myxoid-round cell liposarcoma within the deep soft tissues of the thigh of an 81-year-old male with excellent neoadjuvant re… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 7 publications
(25 reference statements)
0
1
0
Order By: Relevance
“…The myxoid variant accounts for one-third to one-half of all liposarcomas, commonly occurring in a younger demographic with a peak incidence in the fifth decade, in comparison to the dedifferentiated and well-differentiated subtypes which demonstrate peak incidence in the seventh decade. The most common sites of tumor involvement include the lower extremities with a predilection for the medial thigh and popliteal area [10].…”
Section: Discussionmentioning
confidence: 99%
“…The myxoid variant accounts for one-third to one-half of all liposarcomas, commonly occurring in a younger demographic with a peak incidence in the fifth decade, in comparison to the dedifferentiated and well-differentiated subtypes which demonstrate peak incidence in the seventh decade. The most common sites of tumor involvement include the lower extremities with a predilection for the medial thigh and popliteal area [10].…”
Section: Discussionmentioning
confidence: 99%